Neuberger Berman Group LLC boosted its position in shares of Analogic Co. (NASDAQ:ALOG) by 9.5% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 336,517 shares of the medical research company’s stock after purchasing an additional 29,109 shares during the period. Neuberger Berman Group LLC owned approximately 2.70% of Analogic worth $28,183,000 at the end of the most recent reporting period.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Citadel Advisors LLC boosted its stake in Analogic by 88.8% during the 2nd quarter. Citadel Advisors LLC now owns 128,879 shares of the medical research company’s stock valued at $9,363,000 after acquiring an additional 60,614 shares during the last quarter. Renaissance Technologies LLC bought a new position in Analogic during the 1st quarter valued at $1,252,000. Vanguard Group Inc. boosted its stake in Analogic by 3.1% during the 2nd quarter. Vanguard Group Inc. now owns 1,147,408 shares of the medical research company’s stock valued at $83,359,000 after acquiring an additional 34,765 shares during the last quarter. SG Americas Securities LLC boosted its stake in Analogic by 470.7% during the 2nd quarter. SG Americas Securities LLC now owns 7,619 shares of the medical research company’s stock valued at $554,000 after acquiring an additional 6,284 shares during the last quarter. Finally, TIAA CREF Investment Management LLC boosted its stake in Analogic by 33.1% during the 2nd quarter. TIAA CREF Investment Management LLC now owns 56,358 shares of the medical research company’s stock valued at $4,094,000 after acquiring an additional 14,022 shares during the last quarter. 97.68% of the stock is owned by institutional investors and hedge funds.
A number of research analysts have commented on the stock. BidaskClub downgraded shares of Analogic from a “hold” rating to a “sell” rating in a research note on Thursday, December 7th. Jefferies Group restated a “hold” rating and issued a $80.00 price target on shares of Analogic in a research report on Friday, December 8th. Finally, Zacks Investment Research upgraded shares of Analogic from a “hold” rating to a “buy” rating and set a $97.00 price target on the stock in a research report on Friday, December 8th.
Analogic Co. (ALOG) traded down $0.95 during trading on Friday, hitting $84.40. 40,051 shares of the stock were exchanged, compared to its average volume of 74,210. Analogic Co. has a one year low of $66.00 and a one year high of $89.50. The company has a market cap of $1,050.00, a P/E ratio of -14.78, a P/E/G ratio of 4.26 and a beta of 0.86.
Analogic (NASDAQ:ALOG) last posted its quarterly earnings results on Wednesday, December 6th. The medical research company reported $0.75 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.43 by $0.32. Analogic had a negative net margin of 15.06% and a positive return on equity of 5.09%. The company had revenue of $106.90 million for the quarter, compared to the consensus estimate of $100.55 million. During the same period last year, the firm posted $0.43 EPS. The company’s revenue for the quarter was down 11.7% on a year-over-year basis. sell-side analysts expect that Analogic Co. will post 2.86 earnings per share for the current fiscal year.
The firm also recently declared a quarterly dividend, which was paid on Friday, December 29th. Stockholders of record on Friday, December 15th were given a $0.10 dividend. The ex-dividend date was Thursday, December 14th. This represents a $0.40 dividend on an annualized basis and a dividend yield of 0.47%. Analogic’s payout ratio is currently -7.01%.
Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography.
Receive News & Ratings for Analogic Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Analogic and related companies with MarketBeat.com's FREE daily email newsletter.